Psyence Biomedica…
USUSDPsyence Biomedical Ltd. (US:PBM) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 1. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.
O podjetju
- Spletna stran
- psyencebiomed.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sedež
- TORONTO, Canada
- Izvršni direktor
- Jody Aufrichtig
- Zaposleni
- 12
- Delnice v obtoku
- 2.29 mio. na dan 2026-03-31
- Prosto prenosljive delnice
- 2.61 mio.
- Tržna kapitalizacija
- 19.15 mio. USD
- Notranje osebe
- 2.97%
- Institucionalni vlagatelji
- 9.67%
- Panoga (SIC)
- Pharmaceutical Preparations
- FCF
- −4.25 mio. USD
- Dolg
- 10.4 mio. USD
- Dobiček in FCF — za 12 mesecev do 30.09.2025 (najnovejše poročilo podjetja).
Opis
Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
Borze in oznake
| Borza | Oznaka | Valuta | Cena | Vrsta |
|---|---|---|---|---|
| US USA Stocks | PBM | USD | 5.12 +4.92% | navadne delnice |
Novice ta teden
Sporočila za javnost s spletne strani za vlagatelje podjetja, ki se dnevno posodabljajo. Povezave vodijo na spletno stran podjetja. Naslovi so v izvirnem jeziku, kot na spletni strani podjetja.
Največji imetniki
| Imetnik | Delež | Delnice | Datum poročila |
|---|---|---|---|
| AdvisorShares Trust-Advi… | 4.61% | 175 687 | 2026-08-31 |
| Parallel Advisors, LLC | 3.97% | 151 250 | 2026-06-30 |
| AdvisorShares Investment… | 3.2% | 122 184 | 2026-06-30 |
| Morgan Stanley | 0.99% | 37 804 | 2026-06-30 |
| Jane Street Group, LLC | 0.8% | 30 431 | 2026-06-30 |
| Xtx Topco Ltd | 0.4% | 15 094 | 2026-06-30 |
| Citadel Advisors Llc | 0.31% | 11 693 | 2026-06-30 |
| UBS Group AG | 0% | 60 | 2026-06-30 |
| Caitlin John, LLC | 0% | 35 | 2026-06-30 |
